Collect Product
Product Details
Synonyms
DDPAC, FTDP-17, MAPT, MSTD, MTBT1, Tau, PHF-tau, TAU
Source
Human Tau-410, His Tag (TAU-H5143) is expressed from E. coli cells. It contains AA Met 1 - Leu 410 (Accession # P10636-5).
Predicted N-terminus: His
Request for sequenceMolecular Characterization
Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the N-terminus.
The protein has a calculated MW of 44.5 kDa. The protein migrates as 55-65 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).
Endotoxin
Less than 0.01 EU per μg by the LAL method / rFC method.
Purity
>90% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
Formulation
Supplied as 0.2 μm filtered solution in 50 mM Tris, 150 mM NaCl, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
Shipping
This product is supplied and shipped with dry ice, please inquire the shipping cost.
Storage
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- The product MUST be stored at -70°C or lower upon receipt;
- -70°C for 3 months under sterile conditions.
ACRO Quality Management System
Kunden haben auch angesehen
Data Display
SDS-PAGE
Human Tau-410, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).
SEC-MALS
The purity of Human Tau-410, His Tag (Cat. No. TAU-H5143) is more than 90% and the molecular weight of this protein is around 40-60 kDa verified by SEC-MALS.
Report
Bioactivity-ELISA
Immobilized Human Tau-410, His Tag (Cat. No. TAU-H5143) at 1 μg/mL (100 μL/well) can bind Tau Monoclonal Antibody with a linear range of 0.2-4 ng/mL (QC tested).
Protocol
User Reviews Publish Comment
Background Introduction
Frontier Progress
Drug Development Progress- English Name：
Microtubule-associated protein tau
- Category：
- Listed Drugs Count：
1 Details
- Clinical Drugs Count：
46 Details
- Highest R&D Stage：
Approved
Contact Us
Drug Candidate Licensing
